Heron Therapeutics, Inc. · NASDAQ:HRTX

Duarte Ira exercised options for 3,874 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 19, 2026 · Filed Jul 20, 2026

On Jul 19, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 3,874 Heron Therapeutics, Inc. shares, leaving 263,846 shares. Filed Jul 20, 2026 (Form 4).

Options exercised
3,874 shares
Holding after
263,846 shares
Trading plan
No
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 19, 2026Common StockOption exercise3,874264,947Direct
Jul 19, 2026Common StockShares withheld for tax1,101US$0.47263,846Direct

Source

View original at SEC

Related